New fatty liver drug tested in humans for first time
NCT ID NCT05599945
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 21 times
Summary
This early-stage study tested a new medicine called NNC0581-0001 in 48 adults to see if it is safe and how the body handles it. Some participants were healthy, and others had fatty liver (hepatic steatosis). Each person received either the drug or a placebo as a single injection under the skin. The study lasted about 58 weeks and is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel CPRU, Level 7
Harrow, Middlesex, HA1 3UJ, United Kingdom
-
Parexel Research Unit
Harrow, Middlesex, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.